Literature DB >> 28826662

Novel obscurins mediate cardiomyocyte adhesion and size via the PI3K/AKT/mTOR signaling pathway.

Maegen A Ackermann1, Brendan King2, Nicole A P Lieberman2, Prameela J Bobbili3, Michael Rudloff4, Christopher E Berndsen4, Nathan T Wright4, Peter A Hecker5, Aikaterini Kontrogianni-Konstantopoulos6.   

Abstract

The intercalated disc of cardiac muscle embodies a highly-ordered, multifunctional network, essential for the synchronous contraction of the heart. Over 200 known proteins localize to the intercalated disc. The challenge now lies in their characterization as it relates to the coupling of neighboring cells and whole heart function. Using molecular, biochemical and imaging techniques, we characterized for the first time two small obscurin isoforms, obscurin-40 and obscurin-80, which are enriched at distinct locations of the intercalated disc. Both proteins bind specifically and directly to select phospholipids via their pleckstrin homology (PH) domain. Overexpression of either isoform or the PH-domain in cardiomyocytes results in decreased cell adhesion and size via reduced activation of the PI3K/AKT/mTOR pathway that is intimately linked to cardiac hypertrophy. In addition, obscurin-80 and obscurin-40 are significantly reduced in acute (myocardial infarction) and chronic (pressure overload) murine cardiac-stress models underscoring their key role in maintaining cardiac homeostasis. Our novel findings implicate small obscurins in the maintenance of cardiomyocyte size and coupling, and the development of heart failure by antagonizing the PI3K/AKT/mTOR pathway.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Intercalated disc; Obscurin; PI3K/AKT/mTOR; Phosphatidyl-inositol bisphosphates; Pleckstrin homology domain

Mesh:

Substances:

Year:  2017        PMID: 28826662      PMCID: PMC5694667          DOI: 10.1016/j.yjmcc.2017.08.004

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  58 in total

1.  Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.

Authors:  John Rush; Albrecht Moritz; Kimberly A Lee; Ailan Guo; Valerie L Goss; Erik J Spek; Hui Zhang; Xiang-Ming Zha; Roberto D Polakiewicz; Michael J Comb
Journal:  Nat Biotechnol       Date:  2004-12-12       Impact factor: 54.908

Review 2.  Membrane recognition by phospholipid-binding domains.

Authors:  Mark A Lemmon
Journal:  Nat Rev Mol Cell Biol       Date:  2008-02       Impact factor: 94.444

3.  Identification, tissue expression and chromosomal localization of human Obscurin-MLCK, a member of the titin and Dbl families of myosin light chain kinases.

Authors:  Mark W Russell; Maide O Raeker; Kristin A Korytkowski; Kevin J Sonneman
Journal:  Gene       Date:  2002-01-09       Impact factor: 3.688

4.  Disruption of the interface between the pleckstrin homology (PH) and kinase domains of Akt protein is sufficient for hydrophobic motif site phosphorylation in the absence of mTORC2.

Authors:  Noel A Warfel; Matt Niederst; Alexandra C Newton
Journal:  J Biol Chem       Date:  2011-09-09       Impact factor: 5.157

5.  Rapamycin attenuates load-induced cardiac hypertrophy in mice.

Authors:  Tetsuo Shioi; Julie R McMullen; Oleg Tarnavski; Kimber Converso; Megan C Sherwood; Warren J Manning; Seigo Izumo
Journal:  Circulation       Date:  2003-03-17       Impact factor: 29.690

6.  Cardioprotection by resveratrol: a novel mechanism via autophagy involving the mTORC2 pathway.

Authors:  Narasimman Gurusamy; Istvan Lekli; Subhendu Mukherjee; Diptarka Ray; Md Kaimul Ahsan; Mihaela Gherghiceanu; Lawrence M Popescu; Dipak K Das
Journal:  Cardiovasc Res       Date:  2009-12-03       Impact factor: 10.787

7.  Mapping the binding site on small ankyrin 1 for obscurin.

Authors:  Maegen A Borzok; Dawn H Catino; James D Nicholson; Aikaterini Kontrogianni-Konstantopoulos; Robert J Bloch
Journal:  J Biol Chem       Date:  2007-08-25       Impact factor: 5.157

8.  Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload.

Authors:  Julie R McMullen; Megan C Sherwood; Oleg Tarnavski; Li Zhang; Adam L Dorfman; Tetsuo Shioi; Seigo Izumo
Journal:  Circulation       Date:  2004-06-07       Impact factor: 29.690

9.  Lipid binding to the tail domain of vinculin: specificity and the role of the N and C termini.

Authors:  Sean M Palmer; Martin P Playford; Susan W Craig; Michael D Schaller; Sharon L Campbell
Journal:  J Biol Chem       Date:  2008-12-24       Impact factor: 5.157

10.  Investigation of Pathogenic Genes in Chinese sporadic Hypertrophic Cardiomyopathy Patients by Whole Exome Sequencing.

Authors:  Jing Xu; Zhongshan Li; Xianguo Ren; Ming Dong; Jinxin Li; Xingjuan Shi; Yu Zhang; Wei Xie; Zhongsheng Sun; Xiangdong Liu; Qiming Dai
Journal:  Sci Rep       Date:  2015-11-17       Impact factor: 4.379

View more
  16 in total

Review 1.  At the heart of inter- and intracellular signaling: the intercalated disc.

Authors:  Heather R Manring; Lisa E Dorn; Aidan Ex-Willey; Federica Accornero; Maegen A Ackermann
Journal:  Biophys Rev       Date:  2018-06-06

Review 2.  Supporting the heart: Functions of the cardiomyocyte's non-sarcomeric cytoskeleton.

Authors:  Kelly M Grimes; Vikram Prasad; James W McNamara
Journal:  J Mol Cell Cardiol       Date:  2019-04-09       Impact factor: 5.000

Review 3.  New Insights Into the Role of mTOR Signaling in the Cardiovascular System.

Authors:  Sebastiano Sciarretta; Maurizio Forte; Giacomo Frati; Junichi Sadoshima
Journal:  Circ Res       Date:  2018-02-02       Impact factor: 17.367

Review 4.  Unraveling obscurins in heart disease.

Authors:  Alyssa Grogan; Aikaterini Kontrogianni-Konstantopoulos
Journal:  Pflugers Arch       Date:  2018-08-11       Impact factor: 3.657

5.  Patient mutations linked to arrhythmogenic cardiomyopathy enhance calpain-mediated desmoplakin degradation.

Authors:  Ronald Ng; Heather Manring; Nikolaos Papoutsidakis; Taylor Albertelli; Nicole Tsai; Claudia J See; Xia Li; Jinkyu Park; Tyler L Stevens; Prameela J Bobbili; Muhammad Riaz; Yongming Ren; Christopher E Stoddard; Paul Ml Janssen; T Jared Bunch; Stephen P Hall; Ying-Chun Lo; Daniel L Jacoby; Yibing Qyang; Nathan Wright; Maegen A Ackermann; Stuart G Campbell
Journal:  JCI Insight       Date:  2019-06-13

Review 6.  Understanding the molecular basis of cardiomyopathy.

Authors:  Marie-Louise Bang; Julius Bogomolovas; Ju Chen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-11-19       Impact factor: 5.125

7.  Obscurin is a semi-flexible molecule in solution.

Authors:  Jacob A Whitley; Aidan M Ex-Willey; Daniel R Marzolf; Maegen A Ackermann; Anthony L Tongen; Oleksandr Kokhan; Nathan T Wright
Journal:  Protein Sci       Date:  2019-02-06       Impact factor: 6.725

Review 8.  Obscurin: A multitasking giant in the fight against cancer.

Authors:  Talia Guardia; Matthew Eason; Aikaterini Kontrogianni-Konstantopoulos
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2021-05-18       Impact factor: 11.414

9.  Cyanocobalamin prevents cardiomyopathy in type 1 diabetes by modulating oxidative stress and DNMT-SOCS1/3-IGF-1 signaling.

Authors:  Masao Kakoki; Purushotham V Ramanathan; John R Hagaman; Ruriko Grant; Jennifer C Wilder; Joan M Taylor; J Charles Jennette; Oliver Smithies; Nobuyo Maeda-Smithies
Journal:  Commun Biol       Date:  2021-06-23

10.  Hydrostatic pressure suppresses fibrotic changes via Akt/GSK-3 signaling in human cardiac fibroblasts.

Authors:  Ryo Tanaka; Masanari Umemura; Masatoshi Narikawa; Takayuki Fujita; Utako Yokoyama; Tomoaki Ishigami; Kazuo Kimura; Kouichi Tamura; Yoshihiro Ishikawa
Journal:  Physiol Rep       Date:  2018-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.